Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: A systematic review and meta-analysis

Behavioural Brain Research

Volumn 296, Issue , 2016, Pages 61-69

  Chen, Shao wei ^a   Zhong, Xue shan ^a   Jiang, Li na ^a,b   Zheng, Xue yan ^a   Xiong, Yi quan ^a   Ma, Shu juan ^a   Qiu, Min ^a   Huo, Shu ting ^a   Ge, Jing ^a   Chen, Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b Provincial Center for Diseases Control and Prevention of Guangxi   (China)

Author keywords

Autism; Autoimmune diseases; Maternal; Meta analysis; Offspring

Indexed keywords

AUTISM; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; BLOOD BRAIN BARRIER; BLOOD PLACENTA BARRIER; CELL ACTIVATION; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HIGH RISK INFANT; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFLAMMATORY BOWEL DISEASE; MATERNAL DISEASE; MICROGLIA; PRIORITY JOURNAL; PROGENY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; AUTISM SPECTRUM DISORDER; AUTOIMMUNE DISEASES; COMPLICATION; FEMALE; META ANALYSIS; PREGNANCY; PREGNANCY COMPLICATIONS;

AUTISM SPECTRUM DISORDER; AUTOIMMUNE DISEASES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84941077725     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.08.035     Document Type: Review

References (33)

1. Braunschweig D., Van de Water J. Maternal autoantibodies in autism. Arch. Neurol. 2012, 69:693-699.
2. Gesundheit B., Rosenzweig J.P., Naor D., Lerer B., Zachor D.A., Prochazka V., et al. Immunological and autoimmune considerations of Autism Spectrum Disorders. J. Autoimmun. 2013, 44:1-7.
3. Dalton P., Deacon R., Blamire A., Pike M., McKinlay I., Stein J., et al. Maternal neuronal antibodies associated with autism and a language disorder. Ann. Neurol. 2003, 53:533-537.
4. Malkova N.V., Yu C.Z., Hsiao E.Y., Moore M.J., Patterson P.H. Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. Brain Behav. Immun. 2012, 26:607-616.
5. Martin L.A., Ashwood P., Braunschweig D., Cabanlit M., Van de Water J., Amaral D.G. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 2008, 22:806-816.
6. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 2005, 159:151-157.
7. Sweeten T.L., Bowyer S.L., Posey D.J., Halberstadt G.M., McDougle C.J. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003, 112:e420.
8. Brown A.S., Surcel H.M., Hinkka-Yli-Salomaki S., Cheslack-Postava K., Bao Y., Sourander A. Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort. Prog. Neuro-psychopharmacol. Biol. Psychiatry 2015, 57:86-92.
9. Andersen S.L., Laurberg P., Wu C.S., Olsen J. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG 2014, 121:1365-1374.
10. Lyall K., Pauls D.L., Spiegelman D., Ascherio A., Santangelo S.L. Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses' Health Study II. Autism Res. 2012, 5:21-30.
11. Keil A., Daniels J.L., Forssen U., Hultman C., Cnattingius S., Soderberg K.C., et al. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology (Cambridge, Mass) 2010, 21:805-808.
12. Xu G., Jing J., Bowers K., Liu B., Bao W. Maternal diabetes and the risk of autism spectrum disorders in the offspring: a systematic review and meta-analysis. J. Autism Dev. Disord. 2014, 44:766-775.
13. Lyall K., Ashwood P., Van de Water J., Hertz-Picciotto I. Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J. Autism Dev. Disord. 2014, 44:1546-1555.
14. Mouridsen S.E., Rich B., Isager T., Nedergaard N.J. Autoimmune diseases in parents of children with infantile autism: a case-control study. Dev. Med. Child Neurol. 2007, 49:429-432.
15. Higgins J.P., Altman D.G., Gotzsche P.C., Juni P., Moher D., Oxman A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928.
16. G.A.S.B. Wells, D. O'Connell, J. Peterson, V. Welch, M. Losos, P. Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://wwwohrica/programs/clinical_epidemiology/oxfordasp.
17. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 27:557-560.
18. Song F.S.T., Sutton A.J., Abrams K.R., Jones D.R. Methods for exploring heterogeneity in meta-analysis. Eval. Health Prof. 2001, 24:126-151.
19. Hatala R., Keitz S., Wyer P., Guyatt G. Tips for learners of evidence-based medicine: 4. assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ 2005, 172:661-665.
20. Hayashino Y., Noguchi Y., Fukui T. Systematic evaluation and comparison of statistical tests for publication bias. J. Epidemiol. 2005, 15:235-243.
21. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
22. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
23. Trikalinos T.A., Salanti G., Khoury M.J., Ioannidis J.P. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol. 2006, 163:300-309.
24. Comi A.M., Zimmerman A.W., Frye V.H., Law P.A., Peeden J.N. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J. Child Neurol. 1999, 14:388-394.
25. Khaiman C., Onnuam K., Photchanakaew S., Chonchaiya W., Suphapeetiporn K. Risk factors for autism spectrum disorder in the Thai population. Eur. J. Pediatr. 2015, 1-8.
26. Croen L.A., Braunschweig D., Haapanen L., Yoshida C.K., Fireman B., Grether J.K., et al. Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol. Psychiatry 2008, 64:583-588.
27. Enstrom A.M., Van de Water J.A., Ashwood P. Autoimmunity in autism. Curr. Opin. Investig. Drugs 2009, 10:463-473.
28. Lintas C., Sacco R., Garbett K., Mirnics K., Militerni R., Bravaccio C., et al. Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol. Psychiatry 2009, 14:705-718.
29. Warren R.P., Singh V.K., Cole P., Odell J.D., Pingree C.B., Warren W.L., et al. Possible association of the extended MHC haplotype B44-SC30-DR4 with autism. Immunogenetics 1992, 36:203-207.
30. Johnson W.G., Buyske S., Mars A.E., Sreenath M., Stenroos E.S., Williams T.A., et al. HLA-DR4 as a risk allele for autism acting in mothers of probands possibly during pregnancy. Arch. Pediatr. Adolesc. Med. 2009, 163:542-546.
31. Ratajczak H.V. Theoretical aspects of autism: biomarkers-a review. J. immunotoxicol. 2011, 8:80-94.
32. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57:67-81.
33. Morgan J.T., Chana G., Pardo C.A., Achim C., Semendeferi K., Buckwalter J., et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 2010, 68:368-376.